ASU professor offers insights on what may be coming from Neuralink’s PRIME study

This week, Neuralink’s Elon Musk announced that human clinical trials have begun on its Precise Robotically Implanted Brain-Computer Interface (PRIME) study, a medical device trail that uses wireless, brain-computer interface designed to enable people with paralysis to control external devices with their thoughts.

The potential health and economic impact of new tuberculosis vaccines in India

A new preprint discusses how novel tuberculosis vaccines for adolescents and adults could mitigate this problem.

July 14, 2023

Survey: Most Americans believe it’s normal for women to experience pain and incontinence post-childbirth

A new national survey by the Orlando Health Advanced Rehabilitation Institute finds most Americans believe it’s normal for women to experience pain, pressure and incontinence

July 15, 2024

Psilocybin Paper Corrected; Fewer Psychiatrists Billing Medicare; Cannabis and Death

A 2024 meta-analysis on psilocybin’s effects on depression published in The BMJ was corrected earlier this week following methodological errors, but conclusions indicating a benefit

February 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.